Skip to main content

Table 2 Common adverse events in all randomized patients

From: Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

 

Haloperidol (n = 78)

Quetiapine (n = 78)

p value

Akathisia

53 (78%)

0 (0%)

<0.0001

Cold

23 (29.48%)

18 (23%)

0.363

Headache

9 (11.5%)

28 (35.9%)

<0.0001

Fatigue

66 (84.6%)

52 (66.6%)

0.009

Parkinsonism

52 (66.6%)

0 (0%)

<0.0001

Insomnia

37 (47.4%)

41 (52.5%)

0.521

Dizziness

28 (35.9%)

22 (28.2%)

0.303